688373 盟科藥業
按盤價 
8.140 -0.120 (-1.453%) | 2025/06 - 中期 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | -36.865 | -69.243 | -41.120 | -26.660 | -42.749 |
| 總資產報酬率 ROA (%) | -17.099 | -43.686 | -31.593 | -20.532 | -34.349 |
| 投入資產回報率 ROIC (%) | -19.678 | -49.074 | -33.692 | -21.557 | -37.106 | 邊際利潤分析 |
| 銷售毛利率 (%) | 84.785 | 82.801 | 81.608 | 81.699 | 92.449 |
| 營業利潤率 (%) | -206.171 | -333.522 | -452.655 | -462.460 | -3,343.976 |
| 息稅前利潤/營業總收入 (%) | -199.984 | -323.228 | -448.462 | -435.981 | -2,911.436 |
| 淨利潤/營業總收入 (%) | -207.070 | -338.306 | -463.914 | -456.987 | -2,953.915 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 103.160 | 103.870 | 107.841 | 121.401 | 120.365 |
| 價值變動淨收益/利潤總額(%) | -3.075 | -3.931 | -8.032 | -8.394 | -4.654 |
| 營業外收支淨額/利潤總額(%) | 0.351 | 0.005 | 1.024 | -1.200 | -13.224 | 償債能力分析 |
| 流動比率 (X) | 2.668 | 3.526 | 7.715 | 11.906 | 5.410 |
| 速動比率 (X) | 2.470 | 3.277 | 7.441 | 11.716 | 5.293 |
| 資產負債率 (%) | 59.455 | 48.304 | 28.630 | 18.906 | 32.406 |
| 帶息債務/全部投入資本 (%) | 42.898 | 30.632 | 13.112 | 9.154 | 7.511 |
| 股東權益/帶息債務 (%) | 109.259 | 193.434 | 602.728 | 918.363 | 973.704 |
| 股東權益/負債合計 (%) | 68.195 | 107.021 | 249.282 | 428.927 | 208.583 |
| 利息保障倍數 (X) | -28.926 | -31.344 | -50.535 | -20.766 | -69.367 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 91.561 | 74.415 | 65.595 | 46.745 | 66.585 |
| 存貨周轉天數 (天) | 913.815 | 726.712 | 640.488 | 671.209 | 5,171.330 |
| 備註： | 即時報價更新時間為 03/09/2025 11:23 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
